We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
51
Guggenheim Capital
Illinois
– -$21.7M -403,032 Closed
Millennium Management
52
Millennium Management
New York
– -$21.7M -402,509 Closed
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$20.8M -385,500 Closed
Macquarie Group
54
Macquarie Group
Australia
– -$21.5M -381,785 Closed
Deutsche Bank
55
Deutsche Bank
Germany
– -$19.6M -363,614 Closed
Charles Schwab
56
Charles Schwab
California
– -$18.5M -343,731 Closed
PCM
57
Peregrine Capital Management
Minnesota
– -$18.4M -341,048 Closed
FQ
58
First Quadrant
California
– -$18.2M -337,943 Closed
TCIM
59
TIAA CREF Investment Management
New York
– -$17.2M -318,109 Closed
Morgan Stanley
60
Morgan Stanley
New York
– -$16.6M -306,976 Closed
Renaissance Technologies
61
Renaissance Technologies
New York
– -$15.7M -291,200 Closed
PPA
62
Parametric Portfolio Associates
Washington
– -$15M -278,967 Closed
PAI
63
Palo Alto Investors
California
– -$14.3M -264,400 Closed
Neuberger Berman Group
64
Neuberger Berman Group
New York
– -$13.7M -254,882 Closed
Loomis, Sayles & Company
65
Loomis, Sayles & Company
Massachusetts
– -$13.6M -251,914 Closed
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
– -$13.1M -243,432 Closed
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
– -$12.7M -235,650 Closed
Two Sigma Investments
68
Two Sigma Investments
New York
– -$12.7M -235,300 Closed
California Public Employees Retirement System
69
California Public Employees Retirement System
California
– -$12.5M -232,700 Closed
Axa
70
Axa
France
– -$12.1M -224,286 Closed
AIG
71
American International Group
New York
– -$12.1M -224,095 Closed
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
– -$11.7M -217,496 Closed
B
73
Barings
North Carolina
– -$10.8M -199,390 Closed
New York State Teachers Retirement System (NYSTRS)
74
New York State Teachers Retirement System (NYSTRS)
New York
– -$10.7M -198,846 Closed
Point72 Asset Management
75
Point72 Asset Management
Connecticut
– -$10.5M -194,500 Closed
1 2
3
4 5

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.